SUP-T1 cells were harvested, counted and spike-expressing and control SUP-T1 cells were mixed in a 1:1 ratio. The cell mix was transferred into V-bottom 96-well plates at 20,000 cells per well. Cells were incubated with heat-inactivated sera diluted 1:50 in PBS for 30 minutes, washed with FACS buffer (PBS, 5% BSA, 0.05% sodium azide), and stained with FITC anti-IgG (clone HP6017, Biolegend
), APC anti-IgM (clone MHM-88, Biolegend) and
PE anti-IgA (clone IS11–8E10, Miltenyi Biotech) for 30 minutes (all antibodies diluted 1:200 in FACS buffer). Cells were washed with FACS buffer and fixed for 20 minutes in 1% PFA in FACS buffer. Samples were run on a Bio-Rad Ze5 analyser running Bio-Rad Everest software v2.4 and analysed using FlowJo v10.7.1 (Tree Star Inc.) analysis software. Spike-expressing and control SUP-T1 cells were gated and mean fluorescence intensity (MFI) of both populations was measured. MFI in control SUP-T1 cells was subtracted from MFI in spike-expressing SUP-T1 cells, and resulting values were divided by MFI in control SUP-T1 cells to calculate the specific increase in MFI. Values >2 were considered positive.
Fendler A., Au L., Shepherd S.T., Byrne F., Cerrone M., Boos L.A., Rzeniewicz K., Gordon W., Shum B., Gerard C.L., Ward B., Xie W., Schmitt A.M., Joharatnam-Hogan N., Cornish G.H., Pule M., Mekkaoui L., Ng K.W., Carlyle E., Edmonds K., Del Rosario L., Sarker S., Lingard K., Mangwende M., Holt L., Ahmod H., Stone R., Gomes C., Flynn H.R., Agua-Doce A., Hobson P., Caidan S., Howell M., Wu M., Goldstone R., Crawford M., Cubitt L., Patel H., Gavrielides M., Nye E., Snijders A.P., MacRae J.I., Nicod J., Gronthoud F., Shea R.L., Messiou C., Cunningham D., Chau I., Starling N., Turner N., Welsh L., van As N., Jones R.L., Droney J., Banerjee S., Tatham K.C., Jhanji S., O’Brien M., Curtis O., Harrington K., Bhide S., Bazin J., Robinson A., Stephenson C., Slattery T., Khan Y., Tippu Z., Leslie I., Gennatas S., Okines A., Reid A., Young K., Furness A.J., Pickering L., Gandhi S., Gamblin S., Swanton C., Nicholson E., Kumar S., Yousaf N., Wilkinson K.A., Swerdlow A., Harvey R., Kassiotis G., Larkin J., Wilkinson R.J, & Turajlic S. (2021). Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study. Research Square.